Dr Farjo in BBC World News TV Interview
16th August 2012
Dr Bessam Farjo was interviewed by Nick Gowing on ‘The Hub’ program on the BBC World News channel on March 22, 2012.
This was on the back of the latest research unveiled from University of Pennsylvania showing the discovery of PGD2. This is a prostaglandin type molecule that inhibited hair growth in mice. Researchers said they hoped the development or discovery of a compound that suppressed PGD2 would lead to a potential treatment for hair loss. See our hair transplant blog about this.
Our own work with University of Bradford on prostaglandin hair stimulating research is awaiting publication in a peer reviewed journal. This is the same medication that stimulates eyelash hair growth. Watch this space!
In the background behind Dr Farjo is Salford Quays, the beautiful setting for Media City and the new home of the BBC. In fact, HM The Queen and HRH Prince Philip officially opened the site the day after this interview!
Related posts
We’re absolutely delighted to share some very exciting news: the Care Quality Commission (CQC) has upgraded Farjo Hair Institute’s overall rating from Good to Outstanding following its inspection in July. This is the highest possible rating and we couldn’t be prouder. The upgrade was made possible by the recent inspection — our first in over […]
The Farjo Team Attends ISHRS 33rd Annual World Congress in Berlin Last month, the Farjo Hair Institute team travelled to Berlin for the 33rd Annual World Congress of the International Society of Hair Restoration Surgery (ISHRS). The meeting brought together over 1000 attendees including surgeons, scientists and specialists from around the world to share insights, […]
Farjo Recognised Among Best Hair Transplant Surgeons UK by Spear’s Magazine If you’re searching for the best hair loss surgeons in the UK, Farjo Hair Institute should be your trusted destination. With renowned clinics in Manchester and London, Farjo has long set the benchmark for excellence in hair transplant surgery. Recently, two of our leading […]
